- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
More ▼
Key statistics
On Wednesday, Bio Rad Laboratories Inc (BIO:NYQ) closed at 278.21, 6.35% above its 52-week low of 261.59, set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 283.79 |
---|---|
High | 285.27 |
Low | 277.36 |
Bid | 259.44 |
Offer | 292.75 |
Previous close | 285.28 |
Average volume | 245.32k |
---|---|
Shares outstanding | 33.61m |
Free float | 25.07m |
P/E (TTM) | -- |
Market cap | 9.56bn USD |
EPS (TTM) | -21.49 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 00:00 BST.
More ▼